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CD30 Is a CD40-Inducible Molecule that Negatively
Regulates CD40-Mediated Immunoglobulin Class
Switching in Non-Antigen-Selected Human B Cells
proliferation, Ig class switching, and phenotypic differ-
entiation (Van Kooten and Banchereau, 1996), sug-
gesting that CD40 engagement by CD40L is critical for
B cell maturation to plasma cell and memory B cell in
the GC. The central role played by CD40 in the induction
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or enhance CD40-dependent B cell responses have
been identified, including BCR and IL-2, IL-4, and IL-
10 receptors (Van Kooten and Banchereau, 1996), butSummary
surface molecules or signaling pathways that down-
regulate CD40-mediated responses have not been soWe used our monoclonal model of germinal center
far described. Here we have investigated the role ofmaturation, CL-01 B cells, to investigate the role of
CD30 in the regulation of CD40-dependent Ig classCD30 in human B cell differentiation. CL-01 cells are
switching.IgM1IgD1CD301 and switch to IgG, IgA, and IgE when
CD30 is a 120 kDa type I transmembrane glycoproteinexposed to CD40L and IL-4. Switching is hampered by
with sequence homology to members of the tumor ne-CD30 coengagement, possibly through interference
crosis factor receptor (TNFR) superfamily, includingwith the CD40-mediated NF-kB-dependent transcrip-
CD27, CD40, CD95 (Fas), CD120a (TNF-R1), CD120btional activation of downstream CH genes. The physio- (TNF-R2), CD134 (OX40), and CDw137 (4±1BB) (Smithlogical relevance of this phenomenon is emphasized
et al., 1994). Originally identified in Hodgkin and Reed-by similar CD30-mediated effects in naive B cells. Ex-
Sternberg neoplastic cells (Stein et al., 1982), CD30pression of CD30 by these cells is induced by CD40L
subsequently has been shown to be expressed in non-but is inhibited by B cell receptor coengagement and/
Hodgkin B cell lymphomas as well as in virally trans-
or exposure to IL-6 and IL-12. Our data suggest that
formed B cells (Schwarting et al., 1989; DuÈ rkop et al.,
CD30 critically regulates the CD40-mediated differen-
1992). While surface CD30 is virtually absent in normal
tiation of non-antigen-selected human B cells.
circulating B lymphocytes, it has been detected in a
small population of B lymphocytes surrounding the
Introduction GCs of secondary lymphoid organs (Stein et al., 1985;
Schwarting et al., 1989). This finding, together with re-
Recent findings have suggested that stimulation of B ports showing the expression of CD30L (CD153) by acti-
lymphocytes through their antigen receptor (BCR) can vated T cells (Smith et al., 1993), suggests that CD30
be effectively modulated by receptor inhibitory mem- is involved in B:T cell cognate interaction (Clark and
brane-bound molecules, as exemplified by FcgRIIb (Ta- Ledbetter, 1994). However, the physiological stimuli that
kai et al., 1996). Binding of antigen (Ag)-IgG complexes would induce CD30 expression in B cells and the role
to FcgRIIb down-regulates BCR-induced B cell activa- of CD30 in B cell development remain to be defined.
tion and would modulate the response of B cells to Ag Our choice of CD30 as a possible modulator of CD40-
while in the microenvironment of the germinal center driven B cell responses has been suggested by the find-
(GC), thereby dampening or terminating a specific anti- ing that CD30 engagement down-regulates the CD40-
body (Ab) response (O'Rourke et al., 1997). Integrated mediated induction of germline Ie-Ce transcripts in a
inhibitory signaling systems have been identified in T human lymphoblastoid B cell line (Jumper et al., 1995,
cells. For instance, CD152 (CTLA-4) down-regulates the 1996) and by the demonstration that an element of the
responses of CD28-activated T cells by inhibiting their CD30 receptor signaling complex inhibits the activation
IL-2 production (Walunas et al., 1996). The critical nega- of NF-kB (Lee et al., 1997), a crucial component of the
tive regulatory role of CD152 in T cell responses is CD40 signaling pathway (Kehry, 1996). Finally, CD40L
emphasized by the massive lymphoproliferation and is expressed mainly by activated CD41 T cells (Armitage
multiorgan tissue destruction in CD152-deficient mice et al., 1992), whereas CD30L is expressed mainly by
(Tivol et al., 1995). activated CD81 T cells (Smith et al., 1993), suggesting
In addition to Ag and cytokines, CD40 ligand (CD40L, that these two molecules and their receptors may have
CD154) provides a potent stimulus for B cells. CD40L antagonistic regulatory roles.
on T cells engages CD40 on naive B cells to induce In these studies we show that naive surface(s) IgM1
sIgD1CD302 B cells express CD30 upon CD40 engage-
ment by CD40L and are thereafter susceptible to CD30-‖ To whom correspondence should be addressed (e-mail: pcasali@
mail.med.cornell.edu). dependent inhibition of switching to IgG, IgA, and IgE.
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Figure 1. sIgM1sIgD1 CL-01 B Cells Express
Surface CD30 Whose Engagement Nega-
tively Modulates CD40L and IL-4-Induced
Switching to IgG, IgA, and IgE but Not Surface
CD40 Expression
(A and B) Upon incubation for 2 days in me-
dium only or in medium containing 0.5 mg/
ml of htCD40L, 5 mg/ml of control MOPC-21
MAb, or 5 mg/ml of MAb to human CD30,
CL-01 cells were analyzed for expression of
surface CD30 or CD40.
(C and D) CL-01 cells were cultured for 5 days
in medium only or in medium containing IL-4
alone (100 U/ml), htCD40L alone (0.5 mg/ml),
or htCD40L and IL-4 in the presence of either
MOPC-21 oranti-CD30 MAbs (5 mg/ml). Equal
amounts of template cDNA were used to PCR
amplify IH-CH (C), VHDJH-CH (D), and b-actin
transcripts (C and D). Amplified products
were then fractionated into 2% ethidium bro-
mide±stained agarose gel. These findings
were derived from one of three experiments
yielding comparable results.
This inhibition results from an interference with the respectively. CL-01 cells expressed only VHDJH-Cm tran-
scripts (Figure 1D), but failed to express IH-CH and VHDJH-CD40-mediated NF-kB-dependent CH gene transcrip-
tional activation, as suggested by the functional analy- Cg1, -Cg2, -Cg3, -Cg4, -Ca1, -Ca2, and -Ce transcripts
upon incubation with MOPC-21 or anti-CD30 MAbs withsis of the human Cg3 promoter. By showing that BCR
coengagement counteracts the CD40-mediated CD30 or without IL-4 (Figure 1C). Upon exposure to htCD40L,
CL-01 cells expressed Im-Cm, Ig1-Cg1, Ig2-Cg2, Ig3-Cg3,induction, our findings suggest that CD30 negatively
modulates the CD40-dependent differentiation of non- and Ia1-Ca1 as well as VHDJH-Cg1 and VHDJH-Ca1 tran-
scripts. The addition of IL-4 to htCD40L extended germ-Ag-selected human B cells.
line transcription to Ig4-Cg4, Ia2-Ca2, Ie-Ce, and pro-
ductive transcription to VHDJH-Cg2, -Cg3, -Cg4, -Ca2,Results
and -Ce. CD30 coengagement by anti-CD30 MAb or
CD30L on T cells virtually abrogated the expression ofCD30 Engagement Hampers CD40-Mediated
Germline Transcription of Downstream CH both htCD40L2 and htCD40L and IL-4-induced IH-CH
and VHDJH-CH transcripts. This effect was selective, asGenes and Switching to IgG, IgA, and
IgE in Human sIgM1sIgD1 B Cells VHDJH-Cm transcription was spared (Figure 1D), and was
comparably induced by fixed CD81 T cells expressingWe have recently identified a human monoclonal B cell
line, CL-01 cells, that expresses sIgM and sIgD and, CD30L (data not shown). Finally, specific extrachromo-
somal DNA recombination products could be readilyupon exposure to CD40L and IL-4, switches to IgG,
IgA, and IgE (Cerutti et al., 1998). CD30 expression by detected in CL-01 cells exposed to htCD40L and IL-4
(Cerutti et al., 1998), but not after CD30 coengagementunstimulated CL-01 cells (Figure 1A) enabled us to ad-
dress the potential role of this molecule in the modula- (data not shown). Thus, in human B cells, CD30 occu-
pancy hampers CD40L and IL-4-induced CH gene tran-tion of CD40-induced germline IH-CH and productive
VHDJH-CH transcription as well as Ig DNA switch recom- scriptional activation and switch DNA recombination.
The CD30-dependent inhibitory effect onCD40 signal-bination. To mimic the engagement of CD30 by its natu-
ral ligand, the MAb M44 (IgG1), an agonistic mouse MAb ing was not related to the down-regulation of CD40
expression by CL-01 cells, as these cells expressedto human CD30 (Smith et al., 1993; Gruss et al., 1995;
Del Prete et al., 1995), was immobilized onto polystyrene CD40 at comparable density upon incubation with con-
trol MOPC-21 or anti-CD30 MAbs for 2 or 5 days (Figureplates at 5 mg/ml. Immobilized mouse MAb MOPC-21
(IgG1) with irrelevant binding activity was used as con- 1B). Accordingly, CD30 engagement did not hamper the
CD40-mediated up-regulation of surface CD23 (FceRII),trol. In parallel experiments, CD30 was engaged by
CD30L as presented by CD81CD30L1 T cells. To induce CD54 (ICAM-1), CD80 (B7.1), or CD95 (Fas) (data not
shown), further suggesting that CD30 signaling nega-Ig class switching, CL-01 cells were incubated with solu-
ble human trimeric CD40L/leucin zipper fusion protein tively regulates the expression of some, but not all,
CD40-inducible genes.(htCD40L) (0.5 mg/ml) in the presence of IL-4 (100 U/ml).
CL-01 cells were cultured inmedium only or inmedium
containing IL-4 alone, htCD40L alone, or htCD40L and Naive B Cells Express CD30 and GC Phenotypic
Traits When Exposed to CD40LIL-4 in the presence of either immobilized MOPC-21 or
anti-CD30 MAbs. Ig class switching was assessed by sIgM1sIgD1 CL-01 cells constitutively express CD30,
but only a few GC B cells express this member of thethe analysis of germline IH-CH and productive VHDJHm,
g1, g2, g3, g4, a1, a2, and e transcripts, which were TNFR family in vivo (Schwarting et al., 1989). We ana-
lyzed the ability of sIgM1sIgD1 naive B cells to expressamplified from CL-01 cells cultured for 2 and 5 days,
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Figure 2. Normal sIgM1sIgD1 B Cells Express CD30 mRNA, Surface CD30, and GC Markers upon CD40 Engagement by CD40L; BCR
Coengagement Down-Regulates Surface CD30 Expression
Naive B cells were cultured for 3 days in medium only (A) or in medium containing 0.5 mg/ml of htCD40L (B) or htCD40L and 2 mg/ml of anti-k
and anti-l chain (anti-BCR) MAbs (C) and then analyzed for expression of surface CD19, CD30, CD71, CD80, CD86, and CD95. b-actin and
CD30 cDNAs from the same cells were PCR amplified and fractioned into a 2% ethidium bromide±stained agarose gel. These findings were
derived from one of five experiments yielding comparable results.
CD30 mRNA and surface CD30 following CD40 engage- in medium containing 0.5 mg/ml of htCD40L, 100 U/ml
of IL-4, 200 ng/ml of IL-10 (this cytokine was added toment by CD40L. Freshly isolated naive B cells (not
shown) or naive B cells incubated for 3 days in medium increase the B cell proliferation), and 0.5 ng/ml of TGFb1
(this cytokine was used to optimize the IgA secretion)only expressed CD19 (a pan±B cell marker) but lacked
surface CD30 (Figure2A). Upon incubation with htCD40L in the presence of either control MOPC-21 or agonistic
anti-CD30 immobilized MAbs (5 mg/ml). Naive B cells(0.5 mg/ml), about 80% of B cells expressed surface
CD30 and CD30 mRNA as well as the GC markers CD71 were seeded onto MOPC-21 or anti-CD30 MAb coated
plates for an 8 day culture after preincubation in medium(transferrin receptor), CD80, CD86 (B7.2), and CD95
(Fas) (Figure 2B). A time course analysis showed that only or in medium containing htCD40L to up-regulate
CD30 expression. Upon exposure to htCD40L and cyto-surface CD30 expression occurred as early as 24 hr
following CD40 engagement and peaked after 4 days kines, B cells increased IgM secretion and produced
IgG, IgA, and IgE in the presence of MOPC-21 MAb(data not shown). Naive B cells incubated with IL-1b,
IL-2, IL-4, IL-6, IL-7, IL-10, IL-12, IL-13, interferon-g (Figure 4). Consistent with our findings in CL-01 cells,
this IgG, IgA, and IgE, but not IgM, secretion was signifi-(IFNg), IFNa, TGFb1, TNFa, lymphotoxin-b (LTb), or im-
mobilized anti-k and anti-l chain (anti-BCR) MAbs (2 cantly decreased when MOPC-21 MAb was substituted
with anti-CD30 MAb. This CD30-mediated inhibitory ef-mg/ml each) did not express surface CD30 (Figure 3) or
CD30 mRNA (data not shown), unless CD40 was en- fect was not related to a failure of CD40L to engage
appropriate numbers of CD40 molecules, since CD30-gaged by htCD40L. Thus, naive B cells express CD30
upon exposure to CD40L, butnot toother stimuli, includ- stimulated B cells did not down-regulate the expression
of CD40 as compared to unstimulated B cells (data noting BCR engagement and a variety of cytokines.
shown). As members of the TNFR superfamily can be
involved in cell death by apoptosis, we determined theCD30 Engagement Hampers IgG, IgA, and IgE
Secretion by Naive B Cells Induced by CD40L percentage of viable B cells after incubation with MOPC-
21 or anti-CD30 MAbs by trypan blue dye exclusion.and Appropriate Cytokines
We extended our findings to normal human B cells by These experiments showed that the survival of normal
B cells as well as CL-01 cells is comparable in the pres-assessing IgM, IgG, IgA, and IgE secretion in freshly
isolated sIgM1sIgD1 B cells cultured in medium only or ence or in the absence of CD30 ligation (Figure 4).
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of anti-BCR MAbs, IL-6, and IL-12 reduced by up to
80% the CD40-dependent CD30 expression (Figure 3),
but not that of the above GC molecules (not shown). In
agreement with this finding, anti-BCR MAbs prevented
the CD30-dependent inhibition of Ig class switching in
naive B cells cultured with CD40L and appropriate cyto-
kines (Figure 4). Thus, in normal B cells, CD40L-induced
CD30 expression is negatively regulated by BCR coen-
gagement and exposure to IL-6 and/or IL-12.
CD30 Engagement Hampers CD40-Mediated
Transcriptional Activation of the Human
Cg3 Germline Gene Promoter
We have shown that the transcriptional activation of the
human Cg3 germline gene is regulated by the evolution-
ary conserved sequence (ECS) that lies 59 of the corre-
Figure 3. Stimuli Other than CD40L Do Not Induce CD30 Expression
sponding Ig3 region and is synergistically induced byin Normal sIgM1sIgD1 B Cells
CD40L and IL-4 (Schaffer et al., 1998). The CD40-medi-
Naive B cells were cultured for 3 days in medium only or in medium
ated activation of this cis regulatory gene sequencecontaining IL-1b (10 ng/ml), IL-2 (200 U/ml), IL-4 (200 U/ml), IL-7
impinges on a responsive element (RE) that consists of(100 U/ml), IL-10 (200 ng/ml), IL-13 (5 ng/ml), IFNg (200 U/ml), IFNa
(200 U/ml), TNFa (2.5 ng/ml), LTb (2.5 ng/ml), TGFb (0.5 ng/ml), IL-6 two tandemly arrayed NF-kB binding sites.
(200 ng/ml), IL-12 (1 ng/ml), immobilized anti-k and anti-l (anti-BCR) To verify whether the CD30-mediated inhibition of the
MAbs (2 mg/ml each), and a combination of IL-6, IL-12, and anti- CD40-dependent Cg3 germline gene transcription (Fig-
BCR Ab in the presence (full histograms) or in the absence (open ure 1C) was due to an interference with the Cg3 gene
histograms) of htCD40L (0.5 mg/ml). Cells were then reacted with
transcriptional activation, CL-01 cells were transfectedFITC-conjugated anti-CD30 MAb and PE-conjugated anti-CD19
with an ECS-Ig3-pGL3 luciferase gene reporter vectorMAbs and analyzed by flow cytometric analysis. The percentage of
CD191CD301 B cells corresponds to the proportion of cells reacted and then cultured with htCD40L (0.5 mg/ml) and/or IL-4
with the above MAbs that display a fluorescence intensity higher (500 U/ml) in the presence of immobilized control MOPC-
than that displayed by similar cells reacted with control FITC- and 21 or anti-CD30 MAbs (5 mg/ml). After 24 hr, the lucifer-
PE-conjugated isotype matched MAbs. Values are mean 6 SD of ase activity was measured in these induced CL-01 cells
three determinations from three independent experiments.
and expressed as fold induction compared to the basal
activity of cells cultured in medium only. The Cg3 pro-
moter was activated by htCD40L or IL-4, and this activa-Ig class switching has been suggested to be linked
tion was synergistically increased by the combinationto B cell proliferation (Hodgkin et al., 1996). We verified
of these stimuli (Figure 5A). Anti-CD30, but not MOPC-whether CD30 signaling reduces CD40L-induced DNA
21 MAbs, reduced by about 50% the activation inducedsynthesis in naive B cells cultured for 5 days as above.
by htCD40L alone or htCD40L and IL-4, but not thatB cells incubated with control MOPC-21 or anti-CD30
elicited by IL-4 alone. This inhibition was also evidentMAb incorporated [3H]thymidine (TdR) at similar rates in
when CL-01 cells were transfected with an isolated ECS-response to htCD40L and/or cytokines (Figure 4). Similar
Ig3 CD40RE included in a SV40-pGL3 minimal promoterresults were obtained in CL-01 cells (data not shown).
plasmid (Figure 5B). Addition of saturating amounts ofThus, CD30 engagement negatively regulates Ig class
neutralizing anti-IFNg (Figures 5A and 5B), anti-IL-6,switching and secretion, but not proliferation, in normal
anti-IL-10, or anti-TGFb Abs (data not shown) did notB cells induced by CD40L and appropriate cytokines.
reverse the above reported CD30-dependent inhibition,
suggesting that CD30 signaling inhibits the CD40-medi-BCR Engagement, IL-6, and IL-12 Down-Regulate
ated activation of the human Cg3 promoter in a fashionCD40L-Induced Expression of Surface
that is independent of B cell±derived cytokines.CD30 by Naive B Cells
Despite the massive proportion of CD40-responsive B
cells, only a few B cells express surface CD30 in vivo, CD30 Engagement Hampers CD40-Mediated
Binding of p50/p65, p50/c-Rel, and p50/p50suggesting that the CD40-dependent generation of
CD301 B cells is tightly regulated. To identify the stimuli NF-kB Complexes to the CD40 Responsive
Element of the Human Cg3 Germlinepossibly involved in the negative regulation of CD40L-
induced CD30 expression, naive B cells were cocultured Gene Promoter
To verify whether CD30 coengagement is associatedfor 3 days with htCD40L in the presence of the above
reported cytokines and/or immobilized anti-k and anti-l with a decreased binding of NF-kB to the ECS-Ig3
CD40RE, CL-01 cells were cultured in medium only orchain (anti-BCR) MAbs (2 mg/ml each) as a surrogate of
Ag. Most of these stimuli had no significant effect on in medium containing htCD40L (0.5 mg/ml) in the pres-
ence of either control MOPC-21 MAb or anti-CD30 im-the expression of CD30, but BCR engagement or, to
a lesser extent, IL-6 or IL-12 significantly reduced the mobilized MAbs (5 mg/ml). Parallel experiments were
performed using 100 mg/ml of cycloheximide (CHX) asproportion of CD40L-induced CD301 B cells without af-
fecting the expression of the GC markers CD71, CD80, inhibitor of de novo protein synthesis. Nuclear proteins
were extracted after 6 hr of culture, incubated (3 mg)CD86, and CD95 (Figures 2C and 3). The combination
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Figure 4. CD30 Engagement in the Absence of BCR Coengagement Inhibits Ig Class Switching but Not Proliferation in Normal sIgM1sIgD1
B Cells Exposed to CD40L and Appropriate Cytokines
Naive B cells were preincubated for 2 days with medium only, htCD40L (0.5 mg/ml), or htCD40L and immobilized anti-k and anti-l chain (anti-
BCR) MAbs (2 mg/ml each). Cells were then harvested, washed, and seeded in culture plates coated with either MOPC-21 (open histograms)
or anti-CD30 (full histograms) MAbs (5 mg/ml) in the presence of medium only or medium containing IL-4 (100 U/ml) and IL-10 (100 ng/ml);
htCD40L; or htCD40L, IL-4, and IL-10. In selected experiments, TGFb1 (0.5 ng/ml) was added to htCD40L, IL-4, and IL-10 to optimize IgA
secretion. After 8 days, the concentration of IgM, IgG, IgA, and IgE in the culture fluids was measured by ELISA. To measure DNA synthesis,
B cells (1 3 105/well) were cultured as above for 5 days and then pulsed for 18 hr with [3H]TdR. B cells were harvested at day 3 and counted
(200 cells) by trypan blue dye exclusion to measure cell viability. Values are mean 6 SD of four determinations from three independent
experiments.
with a radiolabeled DNA probe spanning the ECS-Ig3 6B, complex C). Shifted bands were specific, as they
were cleared by the preincubation of CD40L-inducedkB1 site (Figure 6A), and then fractioned through a 6%
polyacrylamide gel. nuclear proteins with an excess of unlabeled wild type
(Figure 6B, competitor 1, lane 11), but not mutated, kB1Nuclear proteins from CL-01 cells cultured with con-
trol MOPC21 MAb displayed a weak DNA binding activ- probe (Figure 6B, competitor 2, lane 12). The identity of
complexes A, B, and C to NF-kB/Rel family membersity represented by two shifted bands with slower (Figure
6B, complex A) and faster (Figure 6B, complex B) mobil- was demonstrated by the ability of unlabeled oligonucle-
otides containing a palindromic NF-kB binding se-ity (Figure 6B, lanes 2 and 3). The binding of both com-
plexes was slightly increased by anti-CD30 MAb (Figure quence from the Ig k promoter to compete with the
labeled kB1 probe for binding to CD40L-induced nuclear6B, lanes 4 and 5), while it was dramatically enhanced
by htCD40L (Figure 6B, lanes 6 and 7). CD40L induced proteins (Figure 6B, competitor 3, lane 13). To identify
the composition of kB1-NF-kB complexes A, B, andalso a third complex with the fastest mobility (Figure
Figure 5. CD30 Engagement Down-Regulates the CD40-Mediated NF-kB-Dependent Activation of the Human Cg3 Germline Gene Promoter
CL-01 cells were transiently cotransfected with a pRL-CMV control luciferase plasmid and either a wild-type (wt) ECS-Ig3-pGL3 (LUC) plasmid
(A) or an ECS-Ig3 CD40RE-SV40-pGL3 (LUC) minimal promoter plasmid (B). The top graphics depict the organization of these constructs.
The initiation of transcription within the wt ECS-Ig3 promoter is indicated by an arrow, and numbering is such that 11 corresponds to the
first residue after this initiation site. After transfection, B cells were seeded in culture plates coated with either MOPC-21 (open histograms)
or agonistic anti-CD30 MAbs (full histograms) in medium only or in medium containing IL-4 (500 U/ml); htCD40L (0.5 mg/ml); htCD40L and
IL-4; or htCD40L, IL-4, and anti-IFNg Abs (1:500). Luciferase activity was measured after 24 hr. Values are mean 6 SD of three independent
experiments.
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Figure 6. CD30 Engagement Down-Regulates
the CD40-Mediated Binding of NF-kB to the
CD40RE of the Human Cg3 Germline Gene
Promoter
(A) Sequence of the ECS-Ig3 CD40RE encom-
passed by the kB1 probe. The two kB sites
within the CD40RE are boxed.
(B) CL-01 cells were cultured with MOPC-21
MAb (5 mg/ml), anti-CD30 MAb (5 mg/ml),
MOPC-21 MAband htCD40L (0.5 mg/ml), anti-
CD30 MAb and htCD40L, or anti-CD27 MAb
(5 mg/ml) and htCD40L in the presence or in
the absence of 100 mg/ml of cycloheximide
(CHX). Nuclear proteins were extracted after
6 hr of culture, incubated with a radiolabeled
kB1 oligonucleotide for 30 min, and then frac-
tionated through a 6% polyacrylamide gel
(lanes 2±10; lane 1 corresponds to the pro-
tein-free probe). The specificity of shifted
complexes A, B, and C, and their identity to
NF-kB complexes were established by pre-
incubating nuclear proteins from CD40L-
induced cells with competitors 1 (unlabeled kB1 probe), 2 (unlabeled kB1 mutant), and 3 (palindromic NF-kB binding sequence from the Ig
k promoter) (lanes 11±13). The composition of complexes A, B, and C was determined by preincubating nuclear proteins with rabbit Abs to
human thyreoglobulin (control), p50, p52, p65, c-Rel, or Rel B proteins (lanes 14±19).
C, nuclear proteins from htCD40L-induced cells were that is consistent with a critical role of CD30 in regulating
the CD40-dependent GC B cell differentiation.preincubated for 30 min with a control Ab with irrelevant
Effective T and B lymphocyte responses involve thebinding activity or with Abs to human p50, p52, p65 (Rel
clonal expansion of Ag-specific cells and their differenti-A), c-Rel (Rel), or Rel B proteins. Anti-p50, anti-p65, and
ation into effector cells. This critical phase of expansion/anti-c-Rel Abs decreased kB1 binding by complexes
differentiation is driven by signals delivered by the re-A, B and C, complex A, and complex B, respectively,
ceptor for Ag, costimulatory molecules, and cytokinewhereas control anti-thyreoglobulin, anti-p52, and anti-
receptors, and it is finely tuned by the simultaneousRel B Abs did not (Figure 6B, lanes 14±19), indicating
activation of inhibitory signaling pathways, which likelythat complexes A and B corresponded to p50/p65 and
play a major role in the self-limitation of the immunep50/c-Rel heterodimers, respectively, and complex C
response. In the B cell compartment, CD5 and CD22to p50/p50 homodimers. The addition of anti-CD30 MAb
coreceptors as well as the FcgRIIb molecule negativelygreatly decreased the kB1 binding by p50/p65, p50/c-
regulate BCR-induced B cell responses (O'Rourke et al.,Rel, and p50/p50 complexes regardless of the presence
1997). Since BCR engagement by Ag provides a majorof CHX (Figure 6B, compare lanes 8 and 9 with lanes 6
signal for B cell proliferation, the negative modulationand 7). The specificity of this inhibition was confirmed
of BCR-mediated signals by the above coreceptors mayby the inability of an immobilized MAb to CD27, another
be critical to limit the clonal expansion of Ag-stimulatedTNFR superfamily member expressed by activated nor-
B cells. Signals delivered by cytokine receptorsmay alsomal B cells and CL-01 cells (data not shown), to inhibit
be tuned by inhibitory pathways. Recently, cytokine-the CD40L-induced NF-kB binding (Figure 6B, lane 10).
inducible inhibitors of signaling, such as Janus kinaseA similar CD30-dependent inhibition of NF-kB binding
(Jak)-binding proteins, have been found to down-regu-to the Cg3 CD40RE DNA was achieved using nuclear
late signals emanating from Jak-STAT (signal transducerproteins from freshly isolated normal B cells (data not
and activator of transcription)-coupled cytokine recep-shown). These data indicate that CD30 signaling inhibits
tors, including IL-2, IL-3, IL-4, and IL-6 receptors (Endothe CD40-mediated binding of p50/p65, p50/c-Rel, and
et al., 1997; Naka et al., 1997).p50/p50 NF-kB complexes to the CD40RE of the human
While BCR engagement by Ag is crucial to trigger Ig
Cg3 gene promoter in the absence of de novo protein
somatic hypermutation, CD40 is the major driver of B
synthesis.
cell proliferation and differentiation in the GC (Van
Kooten and Banchereau, 1996; Zan et al., 1998b). Be-
Discussion cause of the critical role of CD40 in the GC B cell devel-
opment, it is conceivable that CD40-mediated B cell
These studies show that in human B cells CD30 effec- responses, including proliferation and differentiation,
tively down-regulates Ig class switching to all down- are finely tuned by the activation of signaling pathways
stream isotypes by inhibiting targeted DNA recombina- that negatively regulate CD40 signaling. This negative
tion to Cg, Ca, and Ce through interference with the feedback would be particularly important to limit the
CD40-mediated NF-kB-dependent CH germline gene proliferation and differentiation of those CD40-activated
transcription. They also show that CD30 is induced in B cells that are not positively selected by the Ag. B cells
naive B cells by engagement of CD40 by CD40L, and express CD95 upon CD40 engagement by CD40L, and
this induction is hampered by BCR engagement and, to CD95 engagement by CD95L would prevent the CD40-
mediated proliferation of non-Ag-selected B cells bya lesser extent, exposure to IL-6 or IL-12, in a fashion
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inducing their apoptosis (Schattner et al., 1995). Here binding of p50/p65, p50/c-Rel, and p50/p50 NF-kB com-
we show that non-Ag-selected B cells express CD30 plexes to this CD40RE, our findings indicate that CD30
upon CD40 engagement by CD40L and that CD30 en- signaling specifically interferes with the CD40-mediated
gagement by CD30L counteracts CD40L:CD40-induced NF-kB dependent transcriptional activation of human Ig
B cell differentiation, including Ig class switching. CH genes. The specificity of this inhibition is suggested
In CL-01 B cells, CD40 engagement by CD40L effec- by our demonstration that cross-linking of CD27, an-
tively induces Im-Cm, Ig1-Cg1, Ig2-Cg2, Ig3-Cg3, and other member of the TNFR superfamily expressed by
Ia1-Ca1 transcription, endogenous TGFb production, activated B cells, including CL-01 cells, does not affect
and eventually switch DNA recombination to Cg1 and the CD40L-induced NF-kB binding to the kB1sequence.
Ca1. The addition of IL-4 extends germline transcription CD40 cross-linking activates NF-kB/Rel family mem-
to Ig4-Cg4, Ia2-Ca2, and Ie-Ce and triggers switch DNA bers by inducing the recruitment of TNFR-associated
recombination to all remaining downstream isotypes, as proteins (TRAFs), including TRAF-2, to the CD40 cyto-
indicated by the detection of the corresponding produc- plasmic domain (Rothe et al., 1995; Kehry, 1996). Accu-
tive Ig transcripts and switch circles (Cerutti et al., 1998). mulating evidence suggests that CD40-mediated B cell
The present experiments show that CD30 signaling in- responses can be altered by signals able to quantita-
hibits the transcriptional activation of all of the above tively and/or qualitatively modify the TRAF composition
CH genes as well as their targeted recombination without of the CD40 receptor complex (KuhneÂ et al., 1997).
interfering with the expression of surface CD40. They Putative inhibitors of the TRAF-2-mediated NF-kB acti-
also show that CD30 coengagement does not interfere vation, including I-TRAF/TANK, A20, TRAF-3, and TRIP,
with the expression of the VHDJH-Cm transcript, nor does a TRAF-2 interacting protein that associates with the
it affect other CD40-mediated B cell responses including CD30 cytoplasmic domain, might be associated with
proliferation, enhancement of IgM secretion, or CD23, the negative regulation of the CD40:TRAF-2 signaling
CD54, CD80, CD86, and CD95 up-regulation (Ranheim pathway (Rothe et al., 1995, 1996; Song et al., 1996; Lee
and Kipps, 1993; Schattner et al., 1995; Hanissian and et al., 1997). Our experiments suggest that the CD30-
Geha, 1997). These CD40-dependent processes would dependent inhibition of CD40L:CD40-induced Ig class
entail the induction of a vast array of transcription fac- switching in human B cells does not rely on CD30-induc-
tors. It is tempting to speculate that CD30 preferentially ible genes, but rather on the modulation of preformed
interferes with those CD40-emanating signaling path-
signal transducers. Triggering of surface CD30 may in-
ways that are related to Ig class switching.
duce recruitment of TRAF-2 to the CD30 cytoplasmic
The signaling pathway by which CD30 inhibits Ig class
domain, thereby subtracting TRAF-2 from its associa-
switching would ultimately impinge on the cis regulatory
tion with the CD40 cytoplasmic domain (Ansieau et al.,
elements that lie upstream of the human CH regions. As 1996). The rapid protease-mediated degradation of
we have shown (Schaffer et al., 1998), engagement of
CD30-bound TRAF-2 might induce depletion of cyto-CD40 by CD40L induces the activation of the Cg3 pro-
solic TRAF-2 and further desensitization of the CD40moter, and this activation isboosted by IL-4. CD30 coen-
receptor complex (Duckett and Thompson, 1997). Angagement reduces the activation of the Cg3 promoter
alternative but not mutually exclusive possibility is thatinduced by CD40L alone and CD40L and IL-4, but not
CD30 cross-linking may alter the balance betweenIL-4 alone, suggesting that CD30 interferes with the
TRAF-2 and inhibitors of the TRAF-2-dependent NF-kBCD40 but not the IL-4 signaling pathway. The failure of
activation such as I-TRAF, A20, and TRAF-3. Finally,neutralizing Abs to IL-6, IL-10, TGFb, or IFNg to affect
simultaneous CD40 and CD30 multimerization mightthe CD30-mediated inhibition of the CD40-driven Cg3
bring the corresponding cognate signaling complexesgermline gene transcriptional activation virtually excludes
in such close proximity that CD30-bound TRIP wouldthe possibility that this inhibition is mediated by endoge-
associate and inhibit CD40-bound TRAF-2. The CD30-nous IL-6, IL-10, TGFb, or IFNg (Gruss et al., 1995; Yoshi-
induced redistribution, decreased availability, and/or in-moto et al., 1997; Cerutti et al., 1998; Zan et al., 1998a),
activation of TRAF-2 might impair the CD40-mediatedwhich are all known to modulate CH gene transcriptional
TRAF-2-dependent activation of NF-kB-inducing kinaseactivation and/or B cell proliferation (Stavnezer et al.,
and IkB kinase, two compounds that mediate NF-kB1996; Morse et al., 1997). Rather, our experiments show
activation by inducing IkB phosphorylation (ReÂ gnier etthat CD30 triggering inhibits the CD40L-induced germ-
al., 1997). These membrane-proximal and other moreline transcription of Cg3 and, possibly, other CH genes
distal models of CD30-mediated interference on CD40by hampering the activation of transcription factors
signals are currently under study.binding to the upstream cis regulatory sequences.
The different outcome of CD40-mediated signals inCD40 cross-linking induces the activation and nuclear
the presence of CD30 engagement by CD30L suggeststranslocation of different NF-kB/Rel family members,
a key regulatory role of CD30 in the homeostasis of GCincluding p50, p65 (Rel A), and c-Rel, which are thought
B cells and is reminescent of the ability of other TNFto regulate the CD40-dependent germline transcription
receptor:ligand pairs such as CD27:CD70 and OX40:of a given CH gene by binding critical DNA elements
OX40L to modulate and complement CD40L:CD40-medi-located within the corresponding upstream promoter
ated B cell responses (Stuber et al., 1995; Jacquot et(Stavnezer, 1996). Accordingly, the CD40-dependent
al., 1997). We have found that naive B cells expresstranscriptional activation of the human Cg3 germline
surface CD30 as early as 24 hr after CD40 engagementgene promoter reliesupon the presence of two tandemly
by CD40L, that is, within the same time frame requiredarrayed kB sites, which bind p50/p65 and p50/c-Rel
by activated T cells to express surface CD30L (Smith etheterodimers as well as p50/p50 homodimers. By show-
ing that CD30 significantly decreases CD40-induced al., 1993). CD40L is expressed by CD41 T cells as early
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Figure 7. Role of CD30 in the Regulation of
Human CD40-Dependent B Cell Differenti-
ation
In the upper limb of the scheme, a naive
CD302 B cell differentiates into a GC B cell
and undergoes switching to IgG, IgA, or IgE
upon CD40 engagement by CD40L ex-
pressed by an activated CD41 T cell and ex-
posure to T cell±derived cytokines. BCR
coengagement by Ag as well as IL-6 and IL-
12 secreted by an activated dendritic cell in-
hibit the expression of CD30 by this GC B cell.
In the lower limb, a naive B cell is activated by
a CD41CD40L1 T cell in the absence of BCR
coengagement by Ag complexes on the sur-
face of a dendritic cell and, therefore, ex-
presses CD30. In this non-Ag-selected B cell, CD40L-induced switching to IgG, IgA, or IgE is negatively modulated through CD30 engagement
by CD30L expressed on either a CD41 or a CD81 T cell.
cell±depleted cells were first reacted with a mouse MAb to humanas 4 hr after appropriate stimulation (Van Kooten and
IgD (Southern Biotechnology Associates, Birmingham, AL), and thenBanchereau, 1996), and CD40 engagement by CD40L
with magnetic Microbeads conjugated with goat anti-mouse IgGinitiates germline transcription of CH genes in B cells (Miltenyi Biotec, Auburn, CA). sIgD1 B cells were segregated using
within a few hours (Stavnezer, 1996). The differential a magnetic sorter MACS (Miltenyi Biotec). CD81CD30L1 T cells were
timing of CD30, CD30L, and CD40L expression further obtained from total T cells after depletion of CD41 T cells with CD4-
coated magnetic beads (Miltenyi Biotec) and incubation with 1:100supports our contention that CD30 is critical for the
phytohemoagglutinin (Life Technologies, Grand Island, NY) and 100regulation of CD40-driven Ig class switching in human
U/ml of IL-2 (Genzyme, Cambridge, MA) for 2 days. For T-B cellB cells. Despite the crucial role played by CD40L:CD40-
cocultures, CD30L1 T cells were fixed in 0.5% paraformaldehydemediated T-B cell contact in the development of normal
and washed twice with PBS. The inhibitory activity of these cells
B cell responses (Aruffo et al., 1993), only rare GC B cells on Ig class switching was critically CD30L-dependent, as it was
express surface CD30, suggesting that the generation of prevented by their preincubation with 10 mg/ml of human CD30-
IgG1 Fc chimeric protein (Immunex, Seattle, WA).these elements is tightly regulated in vivo. By showing
that BCR engagement, IL-6, and IL-12 prevent the
Culture ConditionsCD40L-induced expression of CD30 but not that of GC
B cells were cultured in RPMI 1640 medium supplemented with 5%markers, our findings suggest that human B cells ex-
heat-inactivated FBS (Life Technologies), 2 mM L-glutamine, 100press this TNFR-like molecule upon interaction with
U/mL penicillin, 100 mg/ml streptomycin, and 2% HEPES. CL-01
CD41CD40L1 T cells only in the absence of Ag-pre- cells (104) or naive B cells (105) were seeded in 96-well microculture
senting cells such as dendritic cells (Figure 7). These plates with or without htCD40L (0.5 mg/ml) (Immunex) at the final
cells would antagonize the CD30 expression by B cells volume of 200 ml. T cells were used at 2 3 104 or 2 3 105/well.
MOPC-21 (Sigma Chemicals, St. Louis, MO), anti-CD30 (Immunex),in two ways: by engaging the BCR through Ag com-
and anti-CD27 (Immunotech, Westbrook, ME) MAbs were coatedplexes and by secreting IL-6 and IL-12 in response to
onto polystyrene plates at 5 mg/ml. BCR triggering was performedthe engagement of their surface CD40 by T cell CD40L
using 2 mg/ml of anti-k and anti-l chain MAbs (ICN Pharmaceutical,
(Grewal and Flawell, 1996). BCR engagement has been Costa Mesa, CA). Recombinant human IL-1b, IL-2, IL-6, IL-7, IL-
suggested to inhibit the CD40-mediated up-regulation 13, TGFb1, TNFa, LTb, IFNg (Genzyme Co.), IL-4, IL-10 (Schering-
of another member of the TNFR family, CD95 (Choe et Plough), and IL-12 (a gift from Dr. B. Perussia) were used at a
concentration of 10 ng/ml, 200 U/ml, 200 ng/ml, 100 U/ml, 5 ng/ml,al., 1996; KuhneÂ et al., 1997). The transitory expression
0.5 ng/ml, 2.5 ng/ml, 2.5 ng/ml, 200 U/ml, 100 U/ml, 200 ng/ml, andof CD40L by T cells and/or the rapid cleavage of CD30
1 ng/ml, respectively. Neutralizing Abs to human IFNg (a gift fromthrough disintegrin metalloproteinases released by CD40-
Dr. B. Perussia) as well as to IL-6, IL-10, and TGFb (Genzyme) were
activated dendritic cells (Mueller et al., 1997) may repre- used at 1:500 and 30 mg/ml, respectively. Cycloheximide (Sigma
sent two additional mechanisms limiting the CD30 ex- Chemicals) was used at 100 mg/ml.
pression by B cells in vivo. In conclusion, our findings
indicate that the CD30 pathway represents a negative Fluorescence Flow Cytometry
Mouse fluorescein (FITC)- or phycoerytrin (PE)-conjugated Abs tofeedback limiting the CD40-driven progression of non-
the following human Ags were used: CD40L, CD80, and CD95 (An-Ag-selected B cells into isotype-switched B cells. De-
cell, Bayport, MN); CD54 (Becton Dickinson, San Jose, CA); CD30fects involving the CD30 pathway and/or the processes
and CD71 (Dako, Carpinteria, CA); CD40 and CD86 (PharMingen,
leading to the deletion of CD301 B cells might either San Diego, CA); CD3, CD4, CD8, and CD19 (Sigma Chemicals); and
generate autoreactive B clonotypes secreting IgG, IgA, CD23 (Coulter, Hialeh, FL). Unconjugated mouse M81 MAb to human
or IgE with pathogenic potential and/or favor the neo- CD30L (Immunex) was labeled with FITC-conjugated goat Ab to
mouse Ig (PharMingen). Cells (104) were acquired using a FACScali-plastic transformation of CD301 B cells.
bur analyzer and data were processed using a Macintosh CELL-
Quest software program (Becton Dickinson).Experimental Procedures
Cells Proliferation Assays
B cells (105) were seeded in 96-well U-shapedmicrotiter platesunderThe human CL-01 B cell line has been reported (Cerutti et al., 1998).
Peripheral blood mononuclear cells were isolated from healthy sub- different conditions and pulsed with 1 mCi of [3H]TdR at day 5 of
culture. After 18 hr, cells were harvested for the measurement ofjects and depleted of T cells by sheep red blood cells rosetting. T
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[3H]TdR uptake. The stimulation index was calculated according to center and plasmacytoid phenotypic differentiation in a human
monoclonal IgM1 IgD1 B cell line. J. Immunol. 160, 2145±2157.the formula: mean of cpm of triplicates with stimulus/mean of cpm
of triplicates without stimulus. Choe, J., Kim, H.S., Zhang, X., Armitage, R.J., and Choi, Y.S. (1996).
Cellular and molecular factors that regulate the differentiation and
Amplification of CD30, IH-CH, and VHDJH-CH Transcripts apoptosis of germinal center B cells. Anti-Ig down-regulates Fas
RNA was isolated using the RNeasy Total RNA Kit (Qiagen, Chats- expression on CD40 ligand-stimulated germinal center B cells and
worth, CA), and equal amounts (3 mg) were reversed transcribed inhibits Fas-mediated apoptosis. J. Immunol. 157, 1006±1016.
into cDNAusing the SuperScript reverse transcriptase (Life Technol- Clark, E.A., and Ledbetter, J.A. (1994). How B and T cells talk to
ogies) and an oligo(dT)12±18 primer. cDNA was measured and utilized each other. Nature 367, 425±429.
in equal amounts as template to PCR amplify (20 cycles) IH-CH and Del Prete, G., De Carli, M., D' Elios, M.M., Daniel, K.C., Almerigogna,
VHDJH-CH transcripts and b-actin (Cerutti et al., 1998). To amplify F., Alderson, M., Smith, C.A., Thomas, E., and Romagnani, S. (1995).
CD30 cDNA, PCRs were performed using 1U of Taq polymerase CD30-mediated signaling promotes the development of human T
(Perkin-Elmer Cetus Corp., Norwalk, CT), and the specific sense helper type 2-like T cells. J. Exp. Med. 182, 1655±1661.
59-CACCGGAGGGCCTGCAGGAAGCGAAT-39 and antisense 59-CCC
Duckett, C.S., and Thompson, C.B. (1997). CD30-dependent degra-AGGCCTCACTTTCCAGAGGCAGC-39 primers. The following condi-
dation of TRAF-2: implications for negative regulation of TRAF sig-tions were used: denaturation, 1 min at 948C; annealing, 1 min at
naling and the control of cell survival. Genes Dev. 11, 2810±2821.608C; and extension, 1 min at 728C for 30 cycles.
DuÈ rkop, H., Latza, U., Hummel, M., Eitelbach, F., Seed, B., and Stein,
H. (1992). Molecular cloning and expression of a new member ofLuciferase Gene Reporter Assays
the nerve growth factor receptor family that is characteristic forThe full length (2449 to 1265) ECS-Ig3 region and its CD40RE (2238
Hodgkin's disease. Cell 68, 421±427.to 2188) were cloned into a pGL3 Basic vector and pGL3 Promoter
Endo, T.A, Masuhara, M., Yokkouchi, M., Suzuki, R., Sakamoto, H.,vector, respectively (Schaffer et al., 1998). CL-01 cells (16 3 106/ml)
Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H.,were mixed with 40 ml of plasmid DNA-TE solution containing 20
et al. (1997). A new protein containing a SH2 domain that inhibitsmg of pGL3 vector and 10 ng of pRL-CMV control vector (Promega,
Jak kinases. Nature 387, 921±924.Madison, WI). Electroporation and measurements were performed
as described (Schaffer et al., 1998). Grewal, I.S., and Flawell, R.A. (1996). A central role of CD40 ligand
in the regulation of CD41 T cell responses. Immunol. Today 17,
410±414.Electrophoretic Mobility Shift Assays
B cells were cultured for 6 hr, and nuclear proteins were extracted Gruss, H.-J., Ulrich, D., Braddy, S., Armitage, R.J., and Dower, S.K.
using a modified version of Schreiber's method (Schaffer et al., (1995). Recombinant CD30 ligand and CD40 ligand share common
1998). A double-stranded kB1 oligonucleotide probe encompassing biological activities on Hodgkin and Reed-Sterberg cells. Eur. J.
nucleotides 2236 to 2213 of the Cg3 CD40RE was prepared by Immunol. 25, 2083±2089.
annealing the sense primer 59-GTGTCTGGACTCCCCCTCG-39 to Hanissian, S.H., and Geha, R. (1997). Jak3 is associated with CD40
the antisense primer 59-AGAGGGCGAGGGGGAGTCCAGA-39. This and is critical for CD40 induction of gene expression in B cells.
probe was labeled with [a-32P]dCTP and [a-32P]dGTP using the Immunity 6, 379±387.
Klenow fragment of DNA polymerase I (Boehringer Mannheim, India-
Hodgkin, P.D., Lee, J.H., and Lyons, A.B. (1996). B cell differentiationnapolis, IN). DNA binding reactions and shift assays were performed
and isotype switching is related to division cycle number. J. Exp.
as described (Schaffer et al., 1998). For inhibition assays, nuclear
Med. 184, 277±281.
extracts were preincubated for 30 min with 1 mg/ml of rabbit Abs
Jacquot, S., Kobata, T., Iwata, S., Morimoto, C., and Schlossman,to human thyreoglobulin (control), p50, p52, p65 (Rel A), c-Rel (Rel),
S.F. (1997). CD154/CD40 andCD70/CD27 interactions have differentor Rel B (Santa Cruz Biotechnology, San Diego, CA).
and sequential functions in T cell±dependent B cell responses: en-
hancement of plasma celldifferentiation by CD27 signaling. J. Immu-Acknowledgments
nol. 159, 2652±2657.
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